LAVA-051

DB18395InvestigationalProtein Based Therapies

LAVA-051 is a humanized Vγ9Vδ2-T cell-engaging bispecific antibody.

Mechanism: Pharmacologically active on Antigen-presenting glycoprotein CD1d and T cell receptor delta variable 2
Curator reviewed
Code names: LAVA-051

Resolves to

Targets

What you can answer from here — as of October 23, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with LAVA-051, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.